IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CAMPI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.848
AS - Asia 3.690
NA - Nord America 3.578
SA - Sud America 501
AF - Africa 77
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.751
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.341
CN - Cina 1.139
SG - Singapore 979
GB - Regno Unito 845
IT - Italia 833
DE - Germania 420
SE - Svezia 346
BR - Brasile 311
VN - Vietnam 309
HK - Hong Kong 307
FR - Francia 235
RU - Federazione Russa 217
IN - India 205
NL - Olanda 189
CA - Canada 149
BD - Bangladesh 145
ES - Italia 125
TR - Turchia 116
JP - Giappone 105
IE - Irlanda 101
FI - Finlandia 99
KR - Corea 78
ID - Indonesia 77
UA - Ucraina 77
DK - Danimarca 66
MX - Messico 66
AU - Australia 50
CO - Colombia 50
BE - Belgio 42
CL - Cile 38
GR - Grecia 36
CH - Svizzera 35
PL - Polonia 35
EC - Ecuador 33
PE - Perù 29
AR - Argentina 28
TW - Taiwan 27
EU - Europa 26
PH - Filippine 24
IL - Israele 21
TH - Thailandia 21
CI - Costa d'Avorio 20
RO - Romania 20
AT - Austria 18
MY - Malesia 18
PT - Portogallo 17
CZ - Repubblica Ceca 16
HU - Ungheria 16
NO - Norvegia 16
PK - Pakistan 15
IQ - Iraq 14
IR - Iran 12
SA - Arabia Saudita 12
ZA - Sudafrica 10
MA - Marocco 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
DO - Repubblica Dominicana 7
DZ - Algeria 7
OM - Oman 7
TN - Tunisia 7
BG - Bulgaria 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
AZ - Azerbaigian 5
LB - Libano 5
LU - Lussemburgo 5
RS - Serbia 5
SI - Slovenia 5
UY - Uruguay 5
KZ - Kazakistan 4
LK - Sri Lanka 4
MT - Malta 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
ET - Etiopia 3
HR - Croazia 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
LT - Lituania 3
AL - Albania 2
AM - Armenia 2
CR - Costa Rica 2
GA - Gabon 2
GT - Guatemala 2
KW - Kuwait 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
Totale 11.758
Salva come PNG Salva come JPEG
Città #
Southend 668
Singapore 614
Ashburn 377
Chandler 282
Milan 279
Hong Kong 251
San Jose 225
Beijing 186
Dallas 137
Frankfurt am Main 113
Los Angeles 106
Council Bluffs 99
Seattle 96
Wilmington 95
Dublin 94
Princeton 92
Fairfield 90
New York 90
Guangzhou 78
Ho Chi Minh City 75
Santa Clara 75
Hanoi 71
Ann Arbor 68
Houston 68
Toronto 66
Bengaluru 57
Redwood City 56
Woodbridge 55
Lauterbourg 53
Helsinki 52
Shanghai 52
Jacksonville 51
Jakarta 47
Nanjing 45
Buffalo 42
Cambridge 42
Munich 42
Dearborn 41
Moscow 41
Des Moines 40
Hefei 40
Rome 39
Istanbul 38
Tokyo 38
Paris 36
Jinan 34
Mountain View 34
São Paulo 33
Redmond 32
Chicago 31
Melbourne 31
Seoul 29
Bogotá 27
Columbus 27
Berlin 26
Hangzhou 26
Central 25
Madrid 25
London 24
Shenyang 24
Boardman 23
Lima 23
Athens 22
Changsha 22
Da Nang 22
Phoenix 22
Dong Ket 20
Montreal 20
Nanchang 20
Santiago 20
The Dalles 20
Zhengzhou 20
Abidjan 19
Atlanta 18
Naples 18
Barcelona 17
Brussels 17
Essen 17
Falls Church 17
Sakarya 17
Warsaw 17
Bühl 16
Cangzhou 16
Denver 16
Somerville 16
Washington 16
Andover 15
Belo Horizonte 15
Haiphong 15
New Delhi 15
Pillaro 15
Shenzhen 15
Taipei 15
Mainz 14
Mexico City 14
Amsterdam 13
Chengdu 13
Curitiba 13
Rio de Janeiro 13
Turku 13
Totale 6.419
Salva come PNG Salva come JPEG
Nome #
Prevention of orbitopathy by oral or intravenous steroid prophylaxis in short duration Graves’ disease patients undergoing radioiodine ablation : A prospective randomized control trial study 1.321
Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy 805
Quantification of global ocular motility impairment in graves' orbitopathy by measuring eye muscle ductions 716
Therapy of endocrine disease : Endocrine dilemma : management of Graves' orbitopathy 479
DESCRIZIONE DI UN CASO DI SEVERA INSULINO-RESISTENZA E LIPODISTROFIA PARZIALE, CAUSATO DA UNA MUTAZIONE A CARICO DEL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA (PPAR-GAMMA): CARATTERIZZAZIONE CLINICA E MOLECOLARE. 362
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy. 335
Vitamin D and COVID-19 severity and related mortality : a prospective study in Italy 303
The relationship between liver histology and thyroid function tests in patients with nonalcoholic fatty liver disease (NAFLD) 284
B cell activating factor (BAFF) and BAFF receptor expression in autoimmune and nonautoimmune thyroid diseases 283
Syndromes of hormone resistance in the hypothalamic-pituitary-thyrod axis 279
TBG deficiency: description of two novel mutations associated with complete TBG deficiency and review of the literature 261
Rituximab treatment in patients with active Graves' orbitopathy : effects on proinflammatory and humoral immune reactions 258
Retinal photoreceptor functions are compromised in patients with resistance to thyroid hormone syndrome (RTHβ) 250
Increased cardiovascular morbidity and reduced life expectancy in a large Italian cohort of patients with resistance to thyroid hormone β (RTHβ) 240
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe graves' orbitopathy : a randomized controlled study 237
Thyrotropin-secreting pituitary adenomas : outcome of pituitary surgery and irradiation 230
Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy 213
A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy. 205
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression 204
Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab : an open study 199
Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis 193
Fetal cell microchimerism : a protective role in autoimmune thyroid diseases 191
The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience 190
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy 187
The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection 186
Analysis of a deiodinase 2 polymorphism (oRFa-Asp) in patients with Graves’ disease and controls : preliminary results 183
Pituitary tumours : TSH-secreting adenomas 179
Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy : effects on orbital lymphocytic infiltrates 176
Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans 175
New immunomodulators in the treatment of Graves' ophthalmopathy 172
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy 170
Rituximab induces distinct intraorbital and intrathyroidal effects in one patient satisfactorily treated for graves' ophthalmopathy 169
Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis 168
Tissue sensitivity to thyroid hormones may change over time 166
Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy 165
Impact of resistance to thyroid hormone on the cardiovascular system in adults 162
Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis 159
The IGSF1 deficiency syndrome: characteristics of male and female patients 158
Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis 147
Clinical consequences of variable results in the measurement of free thyroid hormones : unusual presentation of a family with a novel variant in the THRB gene causing resistance to thyroid hormone syndrome 144
A rare mutation of thyroid hormone receptor beta gene in thyroid hormone resistance syndrome 143
Resistance to Thyroid Hormone and Cardiovascular Risk 140
Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement 140
A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia 132
Syndromes of resistance to thyroid hormone action 127
Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart 116
Syndromes of reduced sensitivity to thyroid hormones 101
Syndromes of Resistance to Thyroid Hormone Action 97
Variation in Thyroid Hormone Metabolism May Affect COVID-19 Outcome 78
Vitamin D, adiposity, and cardiometabolic risk: Insights from a multivariable cross-sectional study 68
Thyroid hormone resistance: a novel mutation in thyroid hormone receptor beta (THRB) gene - case report 52
The therapeutic outcome of intravenous steroid therapy for active Graves{'} orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor 48
High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids 9
null 3
Totale 12.158
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021225 0 0 0 0 0 0 0 0 0 0 110 115
2021/20221.202 88 83 55 99 97 68 110 81 154 88 86 193
2022/20231.282 145 163 94 100 113 190 46 94 137 55 68 77
2023/20241.104 62 73 77 104 195 80 60 80 64 82 95 132
2024/20252.231 107 206 67 177 213 96 148 233 144 266 251 323
2025/20263.613 366 263 368 306 350 250 519 184 325 264 418 0
Totale 12.158